Literature DB >> 8241074

A speculative view of atopic dermatitis: barrier dysfunction in pathogenesis.

H Ogawa1, T Yoshiike.   

Abstract

The development of atopy or atopic dermatitis is undoubtedly influenced by immunological abnormality. However, the question of factors which induce tolerance breakthrough and hypersensitivity to non-selective multiple antigens in atopy has remained unanswered. The broad clinical spectrum of this disease cannot be explained simply by allergy or immunological abnormalities. This speculative article is the first attempt to answer these questions and to explain the concept of atopic dermatitis by the barrier dysfunction theory based on our experimental results which demonstrated and increased permeability of the stratum corneum in patients with atopic dermatitis. We consider immunological abnormality and mucocutaneous barrier dysfunction as two major defects of atopy or atopic dermatitis. The wide range of clinical manifestations presented by this disease can be more easily comprehended by partial overlapping of these two core abnormalities. A mucocutaneous barrier defect readily allows penetration of multiple antigens or haptens. Repeated encounters with allergens may induce not only tolerance breakthrough and non-selective hypersensitivities but also enhancement of the allergic inflammation. On the other hand, an allergic inflammation stemming from the immunological abnormalities breaks down barrier functions. This sequence results in a 'vicious circle', which plays the most important role in pathogenesis of atopic dermatitis and probably of other atopic diseases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8241074     DOI: 10.1016/0923-1811(93)90767-j

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  9 in total

1.  The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin.

Authors:  James Q Del Rosso; Jacqueline Levin
Journal:  J Clin Aesthet Dermatol       Date:  2011-09

2.  Repair and maintenance of the epidermal barrier in patients diagnosed with atopic dermatitis: an evaluation of the components of a body wash-moisturizer skin care regimen directed at management of atopic skin.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2011-06

3.  Matriptase-deficient mice exhibit ichthyotic skin with a selective shift in skin microbiota.

Authors:  Tiffany C Scharschmidt; Karin List; Elizabeth A Grice; Roman Szabo; Gabriel Renaud; Chyi-Chia R Lee; Tyra G Wolfsberg; Thomas H Bugge; Julia A Segre
Journal:  J Invest Dermatol       Date:  2009-04-23       Impact factor: 8.551

4.  Topical corticosteroid application and the structural and functional integrity of the epidermal barrier.

Authors:  James Q Del Rosso; Kimberly Cash
Journal:  J Clin Aesthet Dermatol       Date:  2013-11

5.  Therapeutic Effects of Fermented Flax Seed Oil on NC/Nga Mice with Atopic Dermatitis-Like Skin Lesions.

Authors:  Joonhyoung Yang; Sangyeon Min; Seungug Hong
Journal:  Evid Based Complement Alternat Med       Date:  2017-01-19       Impact factor: 2.629

Review 6.  Staphylococcus aureus: an underestimated factor in the pathogenesis of atopic dermatitis?

Authors:  Leszek Blicharz; Lidia Rudnicka; Zbigniew Samochocki
Journal:  Postepy Dermatol Alergol       Date:  2019-02-22       Impact factor: 1.837

Review 7.  Skin barrier defects in atopic dermatitis: From old idea to new opportunity.

Authors:  Takeshi Yoshida; Lisa A Beck; Anna De Benedetto
Journal:  Allergol Int       Date:  2021-12-13       Impact factor: 7.478

8.  Distribution of Cannabinoid Receptors in Keratinocytes of Healthy Dogs and Dogs With Atopic Dermatitis.

Authors:  Roberto Chiocchetti; Margherita De Silva; Francesca Aspidi; Rodrigo Zamith Cunha; Francesca Gobbo; Claudio Tagliavia; Giuseppe Sarli; Maria Morini
Journal:  Front Vet Sci       Date:  2022-07-08

9.  The Clinical Efficacy of Mometasone Furoate in Multi-Lamellar Emulsion for Eczema: A Double-blinded Crossover Study.

Authors:  Duk Han Kim; Hyun Jong Lee; Chun Wook Park; Kyu Han Kim; Kwang Hoon Lee; Byung In Ro; Sang Hyun Cho
Journal:  Ann Dermatol       Date:  2013-02-14       Impact factor: 1.444

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.